Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
NPJ Digital Medicine|April 9, 2025
A group concept mapping study of stakeholder perspectives on digital therapeutics economic value driversYoann Sapanel, L Martin Cloutier, Gabriel Tremblay, et al.
Nucleic Acids Research|September 24, 2014
Tls1 regulates splicing of shelterin components to control telomeric heterochromatin assembly and telomere lengthJiyong Wang, Xavier Tadeo, Haitong Hou, et al.
Genes & Development|March 19, 2016
The proper connection between shelterin components is required for telomeric heterochromatin assemblyJiyong Wang, Allison L Cohen, Anudari Letian, et al.
Plos Genetics|May 31, 2014
The proper splicing of RNAi factors is critical for pericentric heterochromatin assembly in fission yeastScott P Kallgren, Stuart Andrews, Xavier Tadeo, et al.
PNAS Nexus|June 17, 2024
N-of-1 health optimization: Digital monitoring of biomarker dynamics to gamify adherence to metabolic switchingPeter Wang, Xavier Tadeo, Han Shi Jocelyn Chew, et al.
Journal of Medical Internet Research|August 1, 2023
Economic Evaluation Associated With Clinical-Grade Mobile App-Based Digital Therapeutic Interventions: Systematic ReviewYoann Sapanel, Xavier Tadeo, Connor T A Brenna, et al.
NPJ Digital Medicine|August 27, 2024
Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trialAgata Blasiak, Lester W J Tan, Li Ming Chong, et al.
Frontiers in Digital Health|October 29, 2021
Personalised, Rational, Efficacy-Driven Cancer Drug Dosing <i>via</i> an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical TrialBenjamin Kye Jyn Tan, Chong Boon Teo, Xavier Tadeo, et al.
NPJ Precision Oncology|February 21, 2025
Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trialAgata Blasiak, Anh T L Truong, Nigel Foo, et al.
BMJ Open|October 25, 2023
CURATE.AI COR-Tx platform as a digital therapy and digital diagnostic for cognitive function in patients with brain tumour postradiotherapy treatment: protocol for a prospective mixed-methods feasibility clinical trialAlexandria Remus, Xavier Tadeo, Grady Ng Shi Kai, et al.
Pageof 3